One Turn Open the globe →Globe →

Health · Copenhagen, Denmark ·

Novo says Wegovy lowers BMI in children in trial

Novo Nordisk said Wegovy lowered BMI and obesity rates in children in a trial.

Why it matters

Possible first drug for under-12s.

Background

Approved from age 12.

The story so far

  1. Wegovy lowers BMI in children in trial
  2. Novo says Wegovy lowers BMI in children in trial

Follow the whole story →

Sources

This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.

See it on the globe →All of Nov 17's stories

More on health